Repositorio Dspace

Flexible treatment of gestational diabetes mellitus adjusted according to intrauterine fetal growth versus treatment according to strict maternal glycemic parameters: a randomized clinical trial

Mostrar el registro sencillo del ítem

dc.contributor.author Fernández-López, Manuela
dc.contributor.author Blanco-Carnero, José-Eliseo
dc.contributor.author Guardia-Baena, Juan-Manuel
dc.contributor.author de-Paco-Matallana, Catalina
dc.contributor.author Aragón-Alonso, Aurora
dc.contributor.author Hernández-Martínez, Antonio-Miguel
dc.date.accessioned 2025-11-20T07:16:06Z
dc.date.available 2025-11-20T07:16:06Z
dc.date.issued 2022-12
dc.identifier.citation Fernández JÁ, Alconchel F, Frutos MD, Gil E, Gómez-Valles P, Gómez B, et al. Combined use of composite mesh and acellular dermal matrix graft for abdominal wall repair following tumour resection. World J Surg Onc. 28 de agosto de 2024;22(1):226.
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21514
dc.description.abstract INTRODUCTION: To compare the conventional treatment of gestational diabetes mellitus (GDM) with flexible treatment according to the measurement of fetal abdominal circumference (AC) in daily clinical practice. RESEARCH DESIGN AND METHODS: Two hundred and sixty pregnant women diagnosed with GDM before week 34 were randomly placed in two groups: a control group, treated according to maternal capillary glycemia, and an experimental group, treated according to ultrasound parameters of fetal growth. The glycemic targets in the control group were blood glucose levels when fasting and 1 hour postprandial (<95/140 mg/dL). In the experimental group, glycemic targets depended on the percentile (p) of fetal AC: if AC p <75th, then blood glucose targets when fasting and at 1 hour postprandial were <120/180 mg/dL; and if AC p ?75th, then the glycemic targets were <80/120 mg/dL. The follow-up of both groups was scheduled according to the GDM protocol of our diabetes and gestation unit. RESULTS: The study was completed by 246 pregnant women, 125 in the control group and 121 in the experimental group. In the experimental group, insulin treatment and neonatal hypoglycemia were significantly lower (p=0.018 and p 0.035, respectively). No differences were observed in large and small infants according to gestational age. However, macrosomic infants were less frequent in the experimental group, although this difference did not reach statistical significance. In terms of gestation complications, the type of delivery and its complications and the rest of the neonatal complications analyzed, no significant differences were observed. CONCLUSIONS: The treatment of flexible GDM according to the measurement of fetal AC is safe for the mother and the fetus and almost halves the number of pregnant women who require insulin treatment, without increasing the number of ultrasound checks or medical visits.
dc.language.iso eng
dc.publisher BMJ PUBLISHING GROUP
dc.rights http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.rights.uri Atribución-NoComercial-SinDerivadas 3.0 España *
dc.subject.mesh Infant, Newborn
dc.subject.mesh Pregnancy
dc.subject.mesh Female
dc.subject.mesh Humans
dc.subject.mesh Diabetes, Gestational
dc.subject.mesh Blood Glucose
dc.subject.mesh Fetal Macrosomia/epidemiology
dc.subject.mesh Gestational Age
dc.subject.mesh Insulins
dc.title Flexible treatment of gestational diabetes mellitus adjusted according to intrauterine fetal growth versus treatment according to strict maternal glycemic parameters: a randomized clinical trial
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 36593648
dc.relation.publisherversion https://drc.bmj.com/lookup/doi/10.1136/bmjdrc-2022-002915
dc.identifier.doi 10.1136/bmjdrc-2022-002915
dc.journal.title Bmj Open Diabetes Research & Care
dc.identifier.essn 2052-4897


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta